Bevacizumab Market, Global Outlook and Forecast 2022-2028

March 2022 | 73 pages | ID: B0DD5D928B3BEN
Market Monitor Global

Abstracts

Bevacizumab, sold under the trade name Avastin, is a medication used to treat a number of types of cancers and a specific eye disease.

This report contains market size and forecasts of Bevacizumab in global, including the following market information:

Global Bevacizumab Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Bevacizumab Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Bevacizumab companies in 2021 (%)

The global Bevacizumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Avastin (bevacizumab) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bevacizumab include Genentech and Amgen etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bevacizumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bevacizumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bevacizumab Market Segment Percentages, by Type, 2021 (%)

• Avastin (bevacizumab)
• Mvasi (bevacizumab-awwb)

Global Bevacizumab Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bevacizumab Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Eye Diease

Global Bevacizumab Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bevacizumab Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bevacizumab revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Bevacizumab revenues share in global market, 2021 (%)

Key companies Bevacizumab sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Bevacizumab sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Genentech
• Amgen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bevacizumab Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bevacizumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BEVACIZUMAB OVERALL MARKET SIZE

2.1 Global Bevacizumab Market Size: 2021 VS 2028
2.2 Global Bevacizumab Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Bevacizumab Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Bevacizumab Players in Global Market
3.2 Top Global Bevacizumab Companies Ranked by Revenue
3.3 Global Bevacizumab Revenue by Companies
3.4 Global Bevacizumab Sales by Companies
3.5 Global Bevacizumab Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Bevacizumab Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Bevacizumab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bevacizumab Players in Global Market
  3.8.1 List of Global Tier 1 Bevacizumab Companies
  3.8.2 List of Global Tier 2 and Tier 3 Bevacizumab Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Bevacizumab Market Size Markets, 2021 & 2028
  4.1.2 Avastin (bevacizumab)
  4.1.3 Mvasi (bevacizumab-awwb)
4.2 By Type - Global Bevacizumab Revenue & Forecasts
  4.2.1 By Type - Global Bevacizumab Revenue, 2017-2022
  4.2.2 By Type - Global Bevacizumab Revenue, 2023-2028
  4.2.3 By Type - Global Bevacizumab Revenue Market Share, 2017-2028
4.3 By Type - Global Bevacizumab Sales & Forecasts
  4.3.1 By Type - Global Bevacizumab Sales, 2017-2022
  4.3.2 By Type - Global Bevacizumab Sales, 2023-2028
  4.3.3 By Type - Global Bevacizumab Sales Market Share, 2017-2028
4.4 By Type - Global Bevacizumab Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bevacizumab Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Eye Diease
5.2 By Application - Global Bevacizumab Revenue & Forecasts
  5.2.1 By Application - Global Bevacizumab Revenue, 2017-2022
  5.2.2 By Application - Global Bevacizumab Revenue, 2023-2028
  5.2.3 By Application - Global Bevacizumab Revenue Market Share, 2017-2028
5.3 By Application - Global Bevacizumab Sales & Forecasts
  5.3.1 By Application - Global Bevacizumab Sales, 2017-2022
  5.3.2 By Application - Global Bevacizumab Sales, 2023-2028
  5.3.3 By Application - Global Bevacizumab Sales Market Share, 2017-2028
5.4 By Application - Global Bevacizumab Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bevacizumab Market Size, 2021 & 2028
6.2 By Region - Global Bevacizumab Revenue & Forecasts
  6.2.1 By Region - Global Bevacizumab Revenue, 2017-2022
  6.2.2 By Region - Global Bevacizumab Revenue, 2023-2028
  6.2.3 By Region - Global Bevacizumab Revenue Market Share, 2017-2028
6.3 By Region - Global Bevacizumab Sales & Forecasts
  6.3.1 By Region - Global Bevacizumab Sales, 2017-2022
  6.3.2 By Region - Global Bevacizumab Sales, 2023-2028
  6.3.3 By Region - Global Bevacizumab Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Bevacizumab Revenue, 2017-2028
  6.4.2 By Country - North America Bevacizumab Sales, 2017-2028
  6.4.3 US Bevacizumab Market Size, 2017-2028
  6.4.4 Canada Bevacizumab Market Size, 2017-2028
  6.4.5 Mexico Bevacizumab Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Bevacizumab Revenue, 2017-2028
  6.5.2 By Country - Europe Bevacizumab Sales, 2017-2028
  6.5.3 Germany Bevacizumab Market Size, 2017-2028
  6.5.4 France Bevacizumab Market Size, 2017-2028
  6.5.5 U.K. Bevacizumab Market Size, 2017-2028
  6.5.6 Italy Bevacizumab Market Size, 2017-2028
  6.5.7 Russia Bevacizumab Market Size, 2017-2028
  6.5.8 Nordic Countries Bevacizumab Market Size, 2017-2028
  6.5.9 Benelux Bevacizumab Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Bevacizumab Revenue, 2017-2028
  6.6.2 By Region - Asia Bevacizumab Sales, 2017-2028
  6.6.3 China Bevacizumab Market Size, 2017-2028
  6.6.4 Japan Bevacizumab Market Size, 2017-2028
  6.6.5 South Korea Bevacizumab Market Size, 2017-2028
  6.6.6 Southeast Asia Bevacizumab Market Size, 2017-2028
  6.6.7 India Bevacizumab Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Bevacizumab Revenue, 2017-2028
  6.7.2 By Country - South America Bevacizumab Sales, 2017-2028
  6.7.3 Brazil Bevacizumab Market Size, 2017-2028
  6.7.4 Argentina Bevacizumab Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Bevacizumab Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Bevacizumab Sales, 2017-2028
  6.8.3 Turkey Bevacizumab Market Size, 2017-2028
  6.8.4 Israel Bevacizumab Market Size, 2017-2028
  6.8.5 Saudi Arabia Bevacizumab Market Size, 2017-2028
  6.8.6 UAE Bevacizumab Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Genentech
  7.1.1 Genentech Corporate Summary
  7.1.2 Genentech Business Overview
  7.1.3 Genentech Bevacizumab Major Product Offerings
  7.1.4 Genentech Bevacizumab Sales and Revenue in Global (2017-2022)
  7.1.5 Genentech Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Bevacizumab Major Product Offerings
  7.2.4 Amgen Bevacizumab Sales and Revenue in Global (2017-2022)
  7.2.5 Amgen Key News

8 GLOBAL BEVACIZUMAB PRODUCTION CAPACITY, ANALYSIS

8.1 Global Bevacizumab Production Capacity, 2017-2028
8.2 Bevacizumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Bevacizumab Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 BEVACIZUMAB SUPPLY CHAIN ANALYSIS

10.1 Bevacizumab Industry Value Chain
10.2 Bevacizumab Upstream Market
10.3 Bevacizumab Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Bevacizumab Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Bevacizumab in Global Market
Table 2. Top Bevacizumab Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Bevacizumab Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Bevacizumab Revenue Share by Companies, 2017-2022
Table 5. Global Bevacizumab Sales by Companies, (K Units), 2017-2022
Table 6. Global Bevacizumab Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Bevacizumab Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Bevacizumab Product Type
Table 9. List of Global Tier 1 Bevacizumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bevacizumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bevacizumab Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Bevacizumab Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Bevacizumab Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Bevacizumab Sales (K Units), 2017-2022
Table 15. By Type - Global Bevacizumab Sales (K Units), 2023-2028
Table 16. By Application – Global Bevacizumab Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Bevacizumab Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Bevacizumab Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Bevacizumab Sales (K Units), 2017-2022
Table 20. By Application - Global Bevacizumab Sales (K Units), 2023-2028
Table 21. By Region – Global Bevacizumab Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Bevacizumab Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Bevacizumab Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Bevacizumab Sales (K Units), 2017-2022
Table 25. By Region - Global Bevacizumab Sales (K Units), 2023-2028
Table 26. By Country - North America Bevacizumab Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Bevacizumab Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Bevacizumab Sales, (K Units), 2017-2022
Table 29. By Country - North America Bevacizumab Sales, (K Units), 2023-2028
Table 30. By Country - Europe Bevacizumab Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Bevacizumab Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Bevacizumab Sales, (K Units), 2017-2022
Table 33. By Country - Europe Bevacizumab Sales, (K Units), 2023-2028
Table 34. By Region - Asia Bevacizumab Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Bevacizumab Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Bevacizumab Sales, (K Units), 2017-2022
Table 37. By Region - Asia Bevacizumab Sales, (K Units), 2023-2028
Table 38. By Country - South America Bevacizumab Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Bevacizumab Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Bevacizumab Sales, (K Units), 2017-2022
Table 41. By Country - South America Bevacizumab Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Bevacizumab Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Bevacizumab Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Bevacizumab Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Bevacizumab Sales, (K Units), 2023-2028
Table 46. Genentech Corporate Summary
Table 47. Genentech Bevacizumab Product Offerings
Table 48. Genentech Bevacizumab Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Amgen Corporate Summary
Table 50. Amgen Bevacizumab Product Offerings
Table 51. Amgen Bevacizumab Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Bevacizumab Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 53. Global Bevacizumab Capacity Market Share of Key Manufacturers, 2020-2022
Table 54. Global Bevacizumab Production by Region, 2017-2022 (K Units)
Table 55. Global Bevacizumab Production by Region, 2023-2028 (K Units)
Table 56. Bevacizumab Market Opportunities & Trends in Global Market
Table 57. Bevacizumab Market Drivers in Global Market
Table 58. Bevacizumab Market Restraints in Global Market
Table 59. Bevacizumab Raw Materials
Table 60. Bevacizumab Raw Materials Suppliers in Global Market
Table 61. Typical Bevacizumab Downstream
Table 62. Bevacizumab Downstream Clients in Global Market
Table 63. Bevacizumab Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Bevacizumab Segment by Type
Figure 2. Bevacizumab Segment by Application
Figure 3. Global Bevacizumab Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bevacizumab Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bevacizumab Revenue, 2017-2028 (US$, Mn)
Figure 7. Bevacizumab Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Bevacizumab Revenue in 2021
Figure 9. By Type - Global Bevacizumab Sales Market Share, 2017-2028
Figure 10. By Type - Global Bevacizumab Revenue Market Share, 2017-2028
Figure 11. By Type - Global Bevacizumab Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Bevacizumab Sales Market Share, 2017-2028
Figure 13. By Application - Global Bevacizumab Revenue Market Share, 2017-2028
Figure 14. By Application - Global Bevacizumab Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Bevacizumab Sales Market Share, 2017-2028
Figure 16. By Region - Global Bevacizumab Revenue Market Share, 2017-2028
Figure 17. By Country - North America Bevacizumab Revenue Market Share, 2017-2028
Figure 18. By Country - North America Bevacizumab Sales Market Share, 2017-2028
Figure 19. US Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Bevacizumab Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Bevacizumab Sales Market Share, 2017-2028
Figure 24. Germany Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 25. France Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Bevacizumab Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Bevacizumab Sales Market Share, 2017-2028
Figure 33. China Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 37. India Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Bevacizumab Revenue Market Share, 2017-2028
Figure 39. By Country - South America Bevacizumab Sales Market Share, 2017-2028
Figure 40. Brazil Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Bevacizumab Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Bevacizumab Sales Market Share, 2017-2028
Figure 44. Turkey Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Bevacizumab Revenue, (US$, Mn), 2017-2028
Figure 48. Global Bevacizumab Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Bevacizumab by Region, 2021 VS 2028
Figure 50. Bevacizumab Industry Value Chain
Figure 51. Marketing Channels